Shanghai Kaibao Pharmaceutical CO., LTD. is a China-based company principally engaged in research, development, manufacture and distribution of Chinese medicines. The Company's main products are clear away heat and toxic material injections, which are applied in treatment of upper respiratory tract infections, such as cold and pneumonia; pioglitazone hydrochloride tablets, which are applied in treatment of diabetes; captopril sustained-release tablets, which are adopted in treatment of hypertension, as well as doxofylline capsules, which are applied in treatment of asthma and other diseases. The Company's products mainly include small volume injections, tablets, hard capsules, granules, mixtures, syrup and oral liquids, among others. The Company distributes its products in domestic markets. It also involves in the purchase of agricultural and sideline products.